Phase II trial of intraperitoneal cisplatin combined with paclitaxel in patients with ovarian, fallopian tube and primary peritoneal carcinomas

被引:0
|
作者
Landrum, L.
Mannel, R.
McMeekin, D. [1 ]
Moore, K. [1 ]
Hyde, J.
Walker, J. [1 ]
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
268
引用
收藏
页码:S105 / S105
页数:1
相关论文
共 50 条
  • [21] Phase I evaluation of lenvatinib and weekly paclitaxel in patients with recurrent endometrial, ovarian, fallopian tube, or primary peritoneal Cancer
    Backes, Floor J.
    Wei, Lai
    Chen, Min
    Hill, Kasey
    Dzwigalski, Kyle
    Poi, Ming
    Phelps, Mitch
    Salani, Ritu
    Copeland, Larry J.
    Fowler, Jeffrey M.
    Cohn, David E.
    Bixel, Kristin
    Cosgrove, Casey
    Hays, John
    O'Malley, David
    GYNECOLOGIC ONCOLOGY, 2021, 162 (03) : 619 - 625
  • [22] Modulated electro-hyperthermia with weekly paclitaxel or cisplatin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: The KGOG 3030 trial
    Kim, Kidong
    Kim, Jae-Hoon
    Kim, Seung Cheol
    Kim, Yong Beom
    Nam, Byung-Ho
    No, Jae Hong
    Cho, Hanbyoul
    Ju, Woong
    Suh, Dong Hoon
    Kim, Yun Hwan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (01)
  • [23] Germline mutations in Black women with ovarian, fallopian tube and primary peritoneal carcinomas
    Somasegar, Sahana
    Weiss, Arielle
    Norquist, Barbara
    Khasnavis, Nithisha
    Radke, Marc
    Manhardt, Enna
    Pennil, Christopher
    Pennington, Kathryn
    Eckert, Mark
    Chryplewicz, Agnieszka
    Lengyel, Ernst
    Swisher, Elizabeth
    GYNECOLOGIC ONCOLOGY, 2022, 164 (01) : E32 - E32
  • [24] Gemcitabine plus cisplatin in recurrent ovarian, fallopian tube, and primary peritoneal cancer
    Eyada, Mostafa
    Fellman, Bryan M.
    Patel, Shrina
    Michael, Victoria
    Soliman, Pamela T.
    Sims, Travis T.
    How, Jeffrey Andrew
    Jazaeri, Amir A.
    Fleming, Nicole D.
    Ramondetta, Lois M.
    Westin, Shannon Neville
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [25] Dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube, or primary peritoneal carcinomas
    T. Ebata
    M. Yunokawa
    S. Bun
    A. Shimomura
    T. Shimoi
    M. Kodaira
    K. Yonemori
    C. Shimizu
    Y. Fujiwara
    T. Kato
    K. Tamura
    Cancer Chemotherapy and Pharmacology, 2016, 78 : 1283 - 1288
  • [26] Dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube, or primary peritoneal carcinomas
    Ebata, T.
    Yunokawa, M.
    Bun, S.
    Shimomura, A.
    Shimoi, T.
    Kodaira, M.
    Yonemori, K.
    Shimizu, C.
    Fujiwara, Y.
    Kato, T.
    Tamura, K.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (06) : 1283 - 1288
  • [27] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as initial treatment of ovarian, fallopian tube, and primary peritoneal cancer: Preliminary results of a phase II randomized clinical trial
    Diaz-Montes, T. P.
    El-Sharkawy, F.
    Gushchin, V.
    Ryu, H. S.
    Sittig, M.
    Sardi, A.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 35 - 35
  • [28] A Phase II trial of oral capecitabine in patients with platinum and taxane refractory ovarian, fallopian tube, or peritoneal cancer
    Wolf, Judith K.
    Bodurka, Diane C.
    Verschraegen, Claire
    Sun, Charlotte C.
    Branham, Donna
    Jenkins, Alfred D.
    Atkinson, Neely
    Gershenson, David M.
    GYNECOLOGIC ONCOLOGY, 2006, 102 (03) : 468 - 474
  • [29] A phase Ib trial of docetaxel, carboplatin and erlotinib in ovarian, fallopian tube and primary peritoneal cancers
    Vasey, P. A.
    Gore, M.
    Wilson, R.
    Rustin, G.
    Gabra, H.
    Guastalla, J-P
    Lauraine, E. P.
    Paul, J.
    Carty, K.
    Kaye, S.
    BRITISH JOURNAL OF CANCER, 2008, 98 (11) : 1774 - 1780
  • [30] A phase Ib trial of docetaxel, carboplatin and erlotinib in ovarian, fallopian tube and primary peritoneal cancers
    P A Vasey
    M Gore
    R Wilson
    G Rustin
    H Gabra
    J-P Guastalla
    E P Lauraine
    J Paul
    K Carty
    S Kaye
    British Journal of Cancer, 2008, 98 : 1774 - 1780